Description: Rivenprost is a novel, potent and selective agonist for the EP 4 receptor with K i of 0.7, 56, 620, and >10,000 nM for EP 4, EP 3, EP 2, and EP 1, respectively. It has been used to promote EP 4 - mediated bone formation, prevent bone loss related to osteoporosis, drive osteoblast differentiation, and stabilize bone implants.

纯度：≥98%

CAS：256382-08-8